Discover 374 paid clinical trials in Greenville, South Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 374
Active & Responsive
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
for
Intracranial Aneurysm
Location: 15 recruiting locations
Sponsor: Medtronic Neurovascular Clinical Affairs
Sex: All
Age: 18 - 70+
Code: NCT02998229
Recruiting
Active & Responsive
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
for
Moderately to Severely Active Ulcerative Colitis
Location: 44 recruiting locations
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06588855
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
for
Triple Negative Breast Cancer, HER2-negative Breast Cancer,
Location: 10 recruiting locations
Sponsor: Dren Bio
Sex: All
Age: 18+
Code: NCT06999187
Phase1, Recruiting
Active & Responsive
Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients
for
Breast Cancer, Gynecologic Cancers, Mitochondrial Function
Location: 1 recruiting location
Sponsor: University of South Carolina
Sex: Female
Age: 20+
Code: NCT06672497
Recruiting
Active & Responsive
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: 33 recruiting locations
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT06233461
Phase2, Recruiting
Active & Responsive
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
for
Locally Advanced Pancreatic Cancer
Location: 15 recruiting locations
Sponsor: RenovoRx
Sex: All
Age: 18+
Code: NCT03257033
Phase3, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease